Health and wellbeing is the core of a productive and happy life. Identifying and providing answers to the countless medical issues that affect people globally is a critical and never ending challenge. That's why we at Immunosyn are dedicated to improving the quality of life of millions of people who suffer from painful and debilitating diseases by providing access to highly effective and affordable biopharmaceutical products. We have the desire, the ability and the intent to find viable answers and provide attainable solutions for treating a broad range of diseases. We are currently pioneering a pipeline of innovative new medicants with our immediate focus on chronic auto-immune, infectious disease and neurological disorders.
Corporate Overview
Immunosyn is a development stage marketing and distribution company. Our headquarter offices are located in La Jolla, CA, with a regional office in Chicago, IL and a Scientific Advisory Board that is globally positioned. Our first product to be introduced, currently called SF-1019, is believed by our Scientific Advisory Board to be one of a new class of therapeutics made from mammalian cells that may have the ability to dramatically affect many auto-immune, neurological and demyelinating conditions resulting in a rapid reduction of symptoms. SF-1019 will be marketable upon receipt of potential regulatory approval in the appropriate jurisdictions.
Find out more about Immunosyn, its Leadership, Vision, Alliances, Corporate Governance and Products.
View our Corporate Presentation in either its summary or detailed form.
